|
|||||
|
|
An increased percentage of myeloid CD34+ bone marrow cells stratifies intermediate IPSS‐R myelodysplastic syndrome patients into prognostically significant groups |
|
| Authors: | T.‐H. Chen‐Liang A. M. Casado‐Prieto V. Campos‐Rodríguez A. M. Hurtado M. L. Amigo M. D. García‐Malo V. Vicente F. J. Ortuño A. Jerez |
| Affiliation: | Hematology and Medical Oncology Department, Morales Meseguer University Hospital, IMIB‐Arrixaca, University of Murcia, Murcia, Spain |
| Abstract: | |
| Keywords: | flow cytometry myelodysplastic syndromes outcomes |